FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Methylphenidate hydrochloride 10 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Triclosan 20 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
Triclosan 20 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
Loracarbef 40 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Loracarbef 40 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Glucose 400 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Glucose 400 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Oxymetazoline hydrochloride 250 microgram/mL nasal solution Has concentration strength denominator value False un Inferred relationship Some 1
Oxymetazoline hydrochloride 250 microgram/mL nasal solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Fluoride ion (as sodium fluoride) 11 mg/g dental paste Has concentration strength denominator value False un Inferred relationship Some 1
Fluoride ion (as sodium fluoride) 11 mg/g dental paste Count of base of active ingredient False un Inferred relationship Some
Methyl aminolevulinate hydrochloride 168 mg/mL cutaneous cream Has concentration strength denominator value False un Inferred relationship Some 1
Methyl aminolevulinate hydrochloride 168 mg/mL cutaneous cream Count of base of active ingredient False un Inferred relationship Some
Sumatriptan succinate 12 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Sumatriptan succinate 12 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Cyclopentolate hydrochloride 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Cyclopentolate hydrochloride 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Nicotine 458 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Nicotine 458 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Echothiophate iodide 300 microgram/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Echothiophate iodide 300 microgram/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Dexlansoprazole 30 mg gastro-resistant oral capsule Count of base of active ingredient False un Inferred relationship Some
Dexlansoprazole 30 mg gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule Count of base of active ingredient False un Inferred relationship Some
Oxymetazoline hydrochloride 500 microgram/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Oxymetazoline hydrochloride 500 microgram/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Echothiophate iodide 600 microgram/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Echothiophate iodide 600 microgram/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Echothiophate iodide 2.5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Echothiophate iodide 2.5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Romidepsin 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Romidepsin 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Oxymetazoline hydrochloride 500 microgram/mL nasal solution Count of base of active ingredient False un Inferred relationship Some
Oxymetazoline hydrochloride 500 microgram/mL nasal solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Glycerin 10 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Glycerin 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Lidocaine hydrochloride 25 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
Lidocaine hydrochloride 25 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Donepezil hydrochloride 1 mg/mL oral solution Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Donepezil hydrochloride 1 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Donepezil hydrochloride 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Butorphanol tartrate 1 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Butorphanol tartrate 1 mg/mL solution for injection Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Butorphanol tartrate 1 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Clonazepam 250 microgram orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Clonazepam 250 microgram orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Echothiophate iodide 1.25 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Echothiophate iodide 1.25 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Iodine (as povidone iodine) 100 mg/g vaginal gel Has concentration strength denominator value False un Inferred relationship Some 1
Iodine (as povidone iodine) 100 mg/g vaginal gel Count of base of active ingredient False un Inferred relationship Some
Donepezil hydrochloride 5 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Donepezil hydrochloride 5 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Clonazepam 500 microgram orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Clonazepam 500 microgram orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Lidocaine hydrochloride 2 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Lidocaine hydrochloride 2 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Nabumetone 2.5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Nabumetone 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Indacaterol (as indacaterol maleate) 75 microgram/actuation powder for inhalation Count of base of active ingredient False un Inferred relationship Some
Indacaterol (as indacaterol maleate) 75 microgram/actuation powder for inhalation Has presentation strength denominator value False un Inferred relationship Some 1
Clonazepam 1 mg orodispersible tablet Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Clonazepam 1 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Clonazepam 1 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Fluoride ion (as sodium fluoride) 27.2 mg/g dental paste Has concentration strength denominator value False un Inferred relationship Some 1
Fluoride ion (as sodium fluoride) 27.2 mg/g dental paste Count of base of active ingredient False un Inferred relationship Some
Tetrahydrozoline hydrochloride 500 microgram/mL nasal solution Has concentration strength denominator value False un Inferred relationship Some 1
Tetrahydrozoline hydrochloride 500 microgram/mL nasal solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1

Start Previous Page 90 of 217 Next End


This concept is not in any reference sets

Back to Start